Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalizationMaxime Taquet, Hamish McAuley, Aarti Shikotra et al.|Nature Medicine|2023Cited by 96
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of diseaseFelicity Liew, Claudia Efstathiou, Sara Fontanella et al.|Nature Immunology|2024Cited by 91
Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UKMaxime Taquet, Zuzanna Skórniewska, Thomas De Deyn et al.|The Lancet Psychiatry|2024Cited by 60
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthmaShailendra Singh, David G. Lambert, Nikol Sullo et al.|British Journal of Pharmacology|2016Cited by 28
Long COVID research: an update from the PHOSP-COVID Scientific SummitChristopher E. Brightling, Mark Ainsworth, Rachael A Evans et al.|The Lancet Respiratory Medicine|2023Cited by 12